Prophylactic Statin Therapy Can Reduce Cardiovascular Events in People with HIV
A new study shows the use of statin therapy in a primary prevention cohort of patients with HIV on antiretroviral therapy was associated with a 35% reduction in risk of cardiovascular events. The data is being reported at the International AIDS Society Conference.
Anticoagulants Linked to Improved COVID-19 Survival Rate
New data from a New York City-based hospital shows patients on blood thinners had a lower mortality risk due to COVID-19.
What is the Association Between Cardiac Injury and Mortality Among COVID-19 Patients?
A new study is providing more information on the link between cardiac injury and mortality among patients hospitalized with COVID-19.
Study Provides Overview of COVID-19 and Cardiovascular Health
The impact of COVID-19 on cardiovascular health is an urgent question for clinicians around the world during this global pandemic.
Can a Shingles Vaccine Reduce Stroke Risk in Older Adults?
A new study found that the Zoster Vaccine Live not only reduced the risk for shingles but also reduced stroke risk by 16% in older adults.
Trump Announces Intent to Nominate Stephen Hahn, MD, as New FDA Commissioner
Until Hahn's position is confirmed, Brett Giroir, MD, of the Department of Health and Human Services, will serve as acting FDA Commissioner.
Two-Thirds of Pneumonia Patients Receive Excessive Antibiotics
The study found that two-thirds of patients receive excess antibiotic treatment and that every excess day increased a patient's risk of adverse events by 5%.
90th Annual Physician Report Finds Stagnant Wage Growth, Gender Pay Gaps
Medical Economics report finds just 22% of physicians reported a rise in compensation during 2018.
FDA Clears Early Sepsis Indicator
The Early Sepsis Indicator is hematology-based cellular biomarker designed to help emergency department physicians identify patients with sepsis or at an increased risk of developing sepsis.
2 Clarke Drive Cranbury, NJ 08512